Briefly, the lung cancer cell line A549 was engineered to express the fusion product of the endogenous CDKN1A (p21) gene with mVenus (Fig. 1A), enabling the measurement of levels of p53 activation using fluorescence as readout (Fig. EV1A). The gene discussed is CDKN1A; the disease is lung carcinoma.